You are here

AVP-786

Otsuka Drops Alzheimer’s Agitation Drug Following Phase III Failure

BioSpace

Wed, 05/22/24 - 11:20 am

Alzheimer's disease

Alzheimer's agitation

clinical trials

Otsuka Drug Candidate Fails Phase III Alzheimer’s Agitation Study

BioSpace

Tue, 02/13/24 - 11:27 am

clinical trials

Alzheimer's agitation

3 Leading Alzheimer's Disease Drugs in Development After Biogen's Aducanumab Flop

Motley Fool

Sat, 03/30/19 - 12:44 pm

Alzheimer's disease

Axsome Therapeutics

Avanir's AVP-786 meets in Phase III for Alzheimer's agitation

BioCentury

Mon, 03/25/19 - 10:28 pm

Avanir Pharmaceuticals

Alzheimer's disease

Alzheimer's agitation